Clinical Trials
3 trialsNCT00014183 2019-11-07
ZD 1839 in Treating Patients With Stage IV or Recurrent Kidney Cancer
University of Maryland, Baltimore
Phase 2 Completed
NCT00467077 2017-03-17
Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer
California Cancer Consortium
Phase 2 Terminated
NCT00012337 2013-06-24
ZD 1839 in Treating Patients With Metastatic Kidney Cancer
National Cancer Institute (NCI)
Phase 2 Completed